Manager × security

DC Funds, LP HOWL holdings history

WEREWOLF THERAPEUTICS INC · CUSIP 95075A107 · CIK 1869028

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, DC Funds, LP reported 589.10K HOWL (shares), valued at $212.02K, or 16.92% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
16.92%
Shares
589.10K
589,102
Reported value
$212.02K
USD

Shares unchanged; reported value decreased 56.77%, and weight changed -16.09 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 202616.92%589,102SEC filing ↗Filed Aug 14, 2026Combination report
Q1 202633.01%589,102SEC filing ↗Filed May 14, 2026Combination report
Q4 202525.69%589,102SEC filing ↗Filed Feb 13, 2026Combination report
Q3 202537.32%589,102SEC filing ↗Filed Nov 10, 2025Combination report
Q2 202529.83%589,102SEC filing ↗Filed Aug 14, 2025Combination report
Q1 202527.71%589,102SEC filing ↗Filed May 14, 2025Combination report
Q4 202424.47%589,102SEC filing ↗Filed Feb 14, 2025Combination report
Q3 202424.25%589,102SEC filing ↗Filed Nov 14, 2024Combination report
Q2 202423.87%589,102SEC filing ↗Filed Aug 13, 2024Combination report
Q1 202436.89%589,102SEC filing ↗Filed May 14, 2024Combination report
Q4 202327.34%589,102SEC filing ↗Filed Feb 13, 2024Combination report
Q3 202325.95%589,102SEC filing ↗Filed Nov 14, 2023Combination report

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 202325.95%589,102$1.26MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Nov 14, 2023
Q4 202327.34%589,102$2.27MShares unchanged; reported value increased 80.37%, and weight changed +1.39 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 13, 2024
Q1 202436.89%589,102$3.82MShares unchanged; reported value increased 67.88%, and weight changed +9.55 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2024
Q2 202423.87%589,102$1.44MShares unchanged; reported value decreased 62.35%, and weight changed -13.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2024
Q3 202424.25%589,102$1.25MShares unchanged; reported value decreased 13.11%, and weight changed +0.38 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 202424.47%589,102$871.87KShares unchanged; reported value decreased 30.19%, and weight changed +0.22 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 202527.71%589,102$572.73KShares unchanged; reported value decreased 34.31%, and weight changed +3.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2025
Q2 202529.83%589,102$642.12KShares unchanged; reported value increased 12.12%, and weight changed +2.12 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 202537.32%589,102$1.16MShares unchanged; reported value increased 80.73%, and weight changed +7.49 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 10, 2025
Q4 202525.69%589,102$373.20KShares unchanged; reported value decreased 67.84%, and weight changed -11.63 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 13, 2026
Q1 202633.01%589,102$490.49KShares unchanged; reported value increased 31.43%, and weight changed +7.32 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2026
Q2 202616.92%589,102$212.02KShares unchanged; reported value decreased 56.77%, and weight changed -16.09 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
DC Funds, LP · WEREWOLF THERAPEUTICS INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1869028","quarter":"2026Q2","cusip":"95075A107"}

get_institutional_manager_history
{"cik":"1869028","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.